Hillcrest Wealth Advisors Ny, LLC Bristol Myers Squibb CO Transaction History

Hillcrest Wealth Advisors Ny, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $224,846 - $263,378	-3,800 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$61.91 - $67.42 $162,513 - $176,977	-2,625 Reduced 40.86%	3,800 $254,000
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $118,680 - $133,480	-2,000 Reduced 23.74%	6,425 $406,000
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $646,688 - $732,816	-11,200 Reduced 57.07%	8,425 $523,000
Q3 2020 Oct 21, 2020	BUY	$57.43 - $63.64 $1.13 Million - $1.25 Million	19,625 New	19,625 $1.18 Million

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hillcrest Wealth Advisors Ny, LLC, based on Form 13F filings with the SEC.

Stay updated on Hillcrest Wealth Advisors Ny, LLC with notifications on news.